Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs. Medicare enrollees, however, ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 ... prescription drug coverage $1.5 billion in out-of-pocket costs. “Last year we proved that negotiating for ...

The new prices, effective January 2026, are expected to save $6 billion in prescription drug costs annually and reduce out-of-pocket expenses for Medicare beneficiaries by an estimated $1.5 billion.

Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs. Medicare enrollees, however, still won't be able to access the drugs to treat obesity under a federal ...

Opens in a new tab or window The blockbuster diabetes and weight-loss drug semaglutide (Ozempic ... than $2,000 out of pocket means they're probably done paying out-of-pocket [costs] within ...

Besides Ozempic and Wegovy, some of the other medications include ... But some Medicare enrollees should see relief from drug ...

Medicare to negotiate prices for blockbuster drugs like Ozempic and Wegovy, potentially saving enrollees millions.